http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
-
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
-
Progenity (PROG) Announces Issuance of Several Patents Granted by USPTO
-
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
-
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
-
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
-
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
-
Progenity (PROG) Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
-
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
-
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
-
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
-
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
-
Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
-
Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
-
Progenity (PROG) Appoints Surbhi Sarna to its Board
-
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
-
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
-
Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
-
Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
-
Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
-
Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
-
Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline
-
Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline
-
Progenity (PROG) Provides Results from Key Study for Its Targeted Therapeutics Program
-
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
-
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
-
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
-
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
-
Progenity Announces Poster Presentations at Digestive Disease Week 2021
-
Progenity Announces Poster Presentations at Digestive Disease Week 2021
-
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd
-
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd
-
Progenity (PROG) Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
-
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
-
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
-
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
-
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
-
Progenity (PROG) Provides Key Update Regarding its Preecludia Test for Preeclampsia
-
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
-
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
-
Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
-
Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
-
Progenity (PROG) Presents Key Verification Study Data for Preecludia Preeclampsia Rule-out Test at ACOG Annual Meeting
-
Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
-
Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
-
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
-
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
-
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
-
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
-
Progenity (PROG) Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
